328 related articles for article (PubMed ID: 24019529)
1. Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.
Loiarro M; Volpe E; Ruggiero V; Gallo G; Furlan R; Maiorino C; Battistini L; Sette C
J Biol Chem; 2013 Oct; 288(42):30210-30222. PubMed ID: 24019529
[TBL] [Abstract][Full Text] [Related]
2. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.
Loiarro M; Gallo G; Fantò N; De Santis R; Carminati P; Ruggiero V; Sette C
J Biol Chem; 2009 Oct; 284(41):28093-28103. PubMed ID: 19679662
[TBL] [Abstract][Full Text] [Related]
3. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
4. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.
Li C; Zienkiewicz J; Hawiger J
J Biol Chem; 2005 Jul; 280(28):26152-9. PubMed ID: 15849357
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
6. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
[TBL] [Abstract][Full Text] [Related]
7. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.
Medvedev AE; Piao W; Shoenfelt J; Rhee SH; Chen H; Basu S; Wahl LM; Fenton MJ; Vogel SN
J Biol Chem; 2007 Jun; 282(22):16042-53. PubMed ID: 17392283
[TBL] [Abstract][Full Text] [Related]
8. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
9. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.
Yamamoto T; Tsutsumi N; Tochio H; Ohnishi H; Kubota K; Kato Z; Shirakawa M; Kondo N
Mol Immunol; 2014 Mar; 58(1):66-76. PubMed ID: 24316379
[TBL] [Abstract][Full Text] [Related]
10. Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal).
Bovijn C; Desmet AS; Uyttendaele I; Van Acker T; Tavernier J; Peelman F
J Biol Chem; 2013 Apr; 288(17):12054-66. PubMed ID: 23460645
[TBL] [Abstract][Full Text] [Related]
11. A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.
Nagpal K; Plantinga TS; Wong J; Monks BG; Gay NJ; Netea MG; Fitzgerald KA; Golenbock DT
J Biol Chem; 2009 Sep; 284(38):25742-8. PubMed ID: 19509286
[TBL] [Abstract][Full Text] [Related]
12. The scaffold MyD88 acts to couple protein kinase Cepsilon to Toll-like receptors.
Faisal A; Saurin A; Gregory B; Foxwell B; Parker PJ
J Biol Chem; 2008 Jul; 283(27):18591-600. PubMed ID: 18458086
[TBL] [Abstract][Full Text] [Related]
13. R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.
Xiong Y; Song C; Snyder GA; Sundberg EJ; Medvedev AE
J Biol Chem; 2012 Nov; 287(45):38327-37. PubMed ID: 22992740
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection.
Valkov E; Stamp A; Dimaio F; Baker D; Verstak B; Roversi P; Kellie S; Sweet MJ; Mansell A; Gay NJ; Martin JL; Kobe B
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14879-84. PubMed ID: 21873236
[TBL] [Abstract][Full Text] [Related]
16. Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.
Murphy MB; Xiong Y; Pattabiraman G; Manavalan TT; Qiu F; Medvedev AE
J Leukoc Biol; 2015 Dec; 98(6):963-74. PubMed ID: 26310831
[TBL] [Abstract][Full Text] [Related]
17. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
[TBL] [Abstract][Full Text] [Related]
18. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
[TBL] [Abstract][Full Text] [Related]
19. Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
George J; Motshwene PG; Wang H; Kubarenko AV; Rautanen A; Mills TC; Hill AV; Gay NJ; Weber AN
J Biol Chem; 2011 Jan; 286(2):1341-53. PubMed ID: 20966070
[TBL] [Abstract][Full Text] [Related]
20. MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling.
Moncrieffe MC; Bollschweiler D; Li B; Penczek PA; Hopkins L; Bryant CE; Klenerman D; Gay NJ
Structure; 2020 Mar; 28(3):281-289.e3. PubMed ID: 31995744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
